AAAAAA

   
Results: 1-25 | 26-41
Results: 1-25/41
POTENTIATION OF 2-CHLORODEOXYADENOSINE ACTIVITY BY BRYOSTATIN-1 IN THE RESISTANT CHRONIC LYMPHOCYTIC-LEUKEMIA CELL-LINE (WSU-CLL) - ASSOCIATION WITH INCREASED RATIOS OF DCK 5'-NT AND BAX/BCL-2/
Authors: MOHAMMAD RM BECK FWJ KATATO K HAMDY N WALL N ALKATIB A
Citation: Rm. Mohammad et al., POTENTIATION OF 2-CHLORODEOXYADENOSINE ACTIVITY BY BRYOSTATIN-1 IN THE RESISTANT CHRONIC LYMPHOCYTIC-LEUKEMIA CELL-LINE (WSU-CLL) - ASSOCIATION WITH INCREASED RATIOS OF DCK 5'-NT AND BAX/BCL-2/, Biological chemistry, 379(10), 1998, pp. 1253-1261
P53 AND PROTEIN-KINASE-C INDEPENDENT INDUCTION OF GROWTH ARREST AND APOPTOSIS BY BRYOSTATIN-1 IN A HIGHLY METASTATIC MAMMARY EPITHELIAL-CELL LINE - IN-VITRO VERSUS IN-VIVO ACTIVITY
Authors: WANG H MOHAMMAD RM WERDELL J SHEKHAR PVM
Citation: H. Wang et al., P53 AND PROTEIN-KINASE-C INDEPENDENT INDUCTION OF GROWTH ARREST AND APOPTOSIS BY BRYOSTATIN-1 IN A HIGHLY METASTATIC MAMMARY EPITHELIAL-CELL LINE - IN-VITRO VERSUS IN-VIVO ACTIVITY, INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 1(6), 1998, pp. 915-923
BRYOSTATIN-1 DOWN-REGULATES MDR1 AND POTENTIATES VINCRISTINE CYTOTOXICITY IN DIFFUSE LARGE-CELL LYMPHOMA XENOGRAFTS
Authors: ALKATIB AM SMITH MR KAMANDA WS PETTIT GR HAMDAN M MOHAMED AN CHELLADURAI B MOHAMMAD RM
Citation: Am. Alkatib et al., BRYOSTATIN-1 DOWN-REGULATES MDR1 AND POTENTIATES VINCRISTINE CYTOTOXICITY IN DIFFUSE LARGE-CELL LYMPHOMA XENOGRAFTS, Clinical cancer research, 4(5), 1998, pp. 1305-1314
BRYOSTATIN-1 DOWN-REGULATES MDR1 AND POTENTIATES VINCRISTINE CYTOTOXICITY IN DIFFUSE LARGE-CELL LYMPHOMA XENOGRAFTS
Authors: ALKATIB AM SMITH MR KAMANDA WS PETTIT GR HAMDAN M MOHAMED AN CHELLADURAI B MOHAMMAD RM
Citation: Am. Alkatib et al., BRYOSTATIN-1 DOWN-REGULATES MDR1 AND POTENTIATES VINCRISTINE CYTOTOXICITY IN DIFFUSE LARGE-CELL LYMPHOMA XENOGRAFTS, Clinical cancer research, 4(5), 1998, pp. 1305-1314
SUCCESSFUL TREATMENT OF HUMAN CHRONIC LYMPHOCYTIC-LEUKEMIA XENOGRAFTSWITH COMBINATION BIOLOGICAL AGENTS AURISTATIN-PE AND BRYOSTATIN-1
Authors: MOHAMMAD RM VARTERASIAN ML ALMATCHY VP HANNOUDI GN PETTIT GR ALKATIB A
Citation: Rm. Mohammad et al., SUCCESSFUL TREATMENT OF HUMAN CHRONIC LYMPHOCYTIC-LEUKEMIA XENOGRAFTSWITH COMBINATION BIOLOGICAL AGENTS AURISTATIN-PE AND BRYOSTATIN-1, Clinical cancer research, 4(5), 1998, pp. 1337-1343
SUCCESSFUL TREATMENT OF HUMAN CHRONIC LYMPHOCYTIC-LEUKEMIA XENOGRAFTSWITH COMBINATION BIOLOGICAL AGENTS AURISTATIN-PE AND BRYOSTATIN-1
Authors: MOHAMMAD RM VARTERASIAN ML ALMATCHY VP HANNOUDI GN PETTIT GR ALKATIB A
Citation: Rm. Mohammad et al., SUCCESSFUL TREATMENT OF HUMAN CHRONIC LYMPHOCYTIC-LEUKEMIA XENOGRAFTSWITH COMBINATION BIOLOGICAL AGENTS AURISTATIN-PE AND BRYOSTATIN-1, Clinical cancer research, 4(5), 1998, pp. 1337-1343
AN ORTHOTOPIC MODEL OF HUMAN PANCREATIC-CANCER IN SEVERE COMBINED IMMUNODEFICIENT MICE - POTENTIAL APPLICATION FOR PRECLINICAL STUDIES
Authors: MOHAMMAD RM ALKATIB A PETTIT GR VAITKEVICIUS VK JOSHI U ADSAY V MAJUMDAR APN SARKAR FH
Citation: Rm. Mohammad et al., AN ORTHOTOPIC MODEL OF HUMAN PANCREATIC-CANCER IN SEVERE COMBINED IMMUNODEFICIENT MICE - POTENTIAL APPLICATION FOR PRECLINICAL STUDIES, Clinical cancer research, 4(4), 1998, pp. 887-894
AN ORTHOTOPIC MODEL OF HUMAN PANCREATIC-CANCER IN SEVERE COMBINED IMMUNODEFICIENT MICE - POTENTIAL APPLICATION FOR PRECLINICAL STUDIES
Authors: MOHAMMAD RM ALKATIB A PETTIT GR VAITKEVICIUS VK JOSHI U ADSAY V MAJUMDAR APN SARKAR FH
Citation: Rm. Mohammad et al., AN ORTHOTOPIC MODEL OF HUMAN PANCREATIC-CANCER IN SEVERE COMBINED IMMUNODEFICIENT MICE - POTENTIAL APPLICATION FOR PRECLINICAL STUDIES, Clinical cancer research, 4(4), 1998, pp. 887-894
SEQUENTIAL TREATMENT OF HUMAN CHRONIC LYMPHOCYTIC-LEUKEMIA WITH BRYOSTATIN-1 FOLLOWED BY 2-CHLORODEOXYADENOSINE - PRECLINICAL STUDIES
Authors: MOHAMMAD RM KATATO K ALMATCHY VP WALL N LIU KZ SCHULTZ CP MANTSCH HH VARTERASIAN M ALKATIB AM
Citation: Rm. Mohammad et al., SEQUENTIAL TREATMENT OF HUMAN CHRONIC LYMPHOCYTIC-LEUKEMIA WITH BRYOSTATIN-1 FOLLOWED BY 2-CHLORODEOXYADENOSINE - PRECLINICAL STUDIES, Clinical cancer research, 4(2), 1998, pp. 445-453
SEQUENTIAL TREATMENT OF HUMAN CHRONIC LYMPHOCYTIC-LEUKEMIA WITH BRYOSTATIN-1 FOLLOWED BY 2-CHLORODEOXYADENOSINE - PRECLINICAL STUDIES
Authors: MOHAMMAD RM KATATO K ALMATCHY VP WALL N LIU KZ SCHULTZ CP MANTSCH HH VARTERASIAN M ALKATIB AM
Citation: Rm. Mohammad et al., SEQUENTIAL TREATMENT OF HUMAN CHRONIC LYMPHOCYTIC-LEUKEMIA WITH BRYOSTATIN-1 FOLLOWED BY 2-CHLORODEOXYADENOSINE - PRECLINICAL STUDIES, Clinical cancer research, 4(2), 1998, pp. 445-453
SYNERGISTIC INTERACTION OF SELECTED MARINE ANIMAL ANTICANCER DRUGS AGAINST HUMAN DIFFUSE LARGE-CELL LYMPHOMA
Authors: MOHAMMAD RM PETTIT GR ALMATCHY VP WALL N VARTERASIAN M ALKATIB A
Citation: Rm. Mohammad et al., SYNERGISTIC INTERACTION OF SELECTED MARINE ANIMAL ANTICANCER DRUGS AGAINST HUMAN DIFFUSE LARGE-CELL LYMPHOMA, Anti-cancer drugs, 9(2), 1998, pp. 149-156
ESTABLISHMENT OF A HUMAN PANCREATIC TUMOR XENOGRAFT MODEL - POTENTIALAPPLICATION FOR PRECLINICAL EVALUATION OF NOVEL THERAPEUTIC AGENTS
Authors: MOHAMMAD RM DUGAN MC MOHAMED AN ALMATCHY VP FLAKE TM DERGHAM ST SHIELDS AF ALKATIB AA VAITKEVICIUS VK SARKAR FH
Citation: Rm. Mohammad et al., ESTABLISHMENT OF A HUMAN PANCREATIC TUMOR XENOGRAFT MODEL - POTENTIALAPPLICATION FOR PRECLINICAL EVALUATION OF NOVEL THERAPEUTIC AGENTS, Pancreas, 16(1), 1998, pp. 19-25
PHASE-I STUDY OF BRYOSTATIN-1 IN PATIENTS WITH RELAPSED NON-HODGKINS-LYMPHOMA AND CHRONIC LYMPHOCYTIC-LEUKEMIA
Authors: VARTERASIAN ML MOHAMMAD RM EILENDER DS HULBURD K RODRIGUEZ DH PEMBERTON PA PLUDA JM DAN MD PETTIT GR CHEN BDM ALKATIB AM
Citation: Ml. Varterasian et al., PHASE-I STUDY OF BRYOSTATIN-1 IN PATIENTS WITH RELAPSED NON-HODGKINS-LYMPHOMA AND CHRONIC LYMPHOCYTIC-LEUKEMIA, Journal of clinical oncology, 16(1), 1998, pp. 56-62
SIMILARITIES BETWEEN THE SENSITIVITY TO 2-CHLORODEOXYADENOSINE OF LYMPHOCYTES FROM CLL PATIENTS AND BRYOSTATIN-1-TREATED WSU-CLL CELLS - ANINFRARED SPECTROSCOPIC STUDY
Authors: LIU KZ SCHULTZ CP MOHAMMAD RM ALKATIB AM JOHNSTON JB MANTSCH HK
Citation: Kz. Liu et al., SIMILARITIES BETWEEN THE SENSITIVITY TO 2-CHLORODEOXYADENOSINE OF LYMPHOCYTES FROM CLL PATIENTS AND BRYOSTATIN-1-TREATED WSU-CLL CELLS - ANINFRARED SPECTROSCOPIC STUDY, Cancer letters, 127(1-2), 1998, pp. 185-193
PRECLINICAL EVALUATION OF MARINE ANIMAL PRODUCTS IN DIFFUSE LARGE-CELL LYMPHOMA XENOGRAFTS
Authors: MOHAMMAD RM VARTERASIAN ML ALMATCHY VP LIMVARAPUSS C PETTIT GR ALKATIB A
Citation: Rm. Mohammad et al., PRECLINICAL EVALUATION OF MARINE ANIMAL PRODUCTS IN DIFFUSE LARGE-CELL LYMPHOMA XENOGRAFTS, Experimental hematology, 25(8), 1997, pp. 396-396
SUCCESSFUL TREATMENT OF CHRONIC LYMPHOCYTIC-LEUKEMIA (CLL) XENOGRAFTSWITH MARINE ANIMAL PRODUCTS
Authors: ALKATIB A VARTERASIAN ML ALMATCHY VP PETTIT GR MOHAMMAD RM
Citation: A. Alkatib et al., SUCCESSFUL TREATMENT OF CHRONIC LYMPHOCYTIC-LEUKEMIA (CLL) XENOGRAFTSWITH MARINE ANIMAL PRODUCTS, Experimental hematology, 25(8), 1997, pp. 498-498
BRYOSTATIN 1-INDUCED DIFFERENTIATION OF A B-CLL CELL-LINE AS DETERMINATED BY FT-IR SPECTROSCOPY
Authors: LIU KZ SCHULTZ CP MOHAMMAD RM ALKATIB A MANTSCH HH
Citation: Kz. Liu et al., BRYOSTATIN 1-INDUCED DIFFERENTIATION OF A B-CLL CELL-LINE AS DETERMINATED BY FT-IR SPECTROSCOPY, Experimental hematology, 25(8), 1997, pp. 502-502
BRYOSTATIN-1 (BRYO1)-INDUCED MONOCYTIC DIFFERENTIATION IN THP-1 - HUMAN LEUKEMIA-CELLS IS ASSOCIATED WITH ENHANCED C-FYN TYROSINE KINASE AND M-CSF RECEPTORS
Authors: LI Y MOHAMMAD RM ALKATIB A VARTERASIAN ML CHEN B
Citation: Y. Li et al., BRYOSTATIN-1 (BRYO1)-INDUCED MONOCYTIC DIFFERENTIATION IN THP-1 - HUMAN LEUKEMIA-CELLS IS ASSOCIATED WITH ENHANCED C-FYN TYROSINE KINASE AND M-CSF RECEPTORS, Leukemia research, 21(5), 1997, pp. 391-397
THE NOVEL CYCLIN-DEPENDENT KINASE INHIBITOR FLAVOPIRIDOL DOWN-REGULATES BCL-2 AND INDUCES GROWTH ARREST AND APOPTOSIS IN CHRONIC B-CELL LEUKEMIA LINES
Authors: KONIG A SCHWARTZ GK MOHAMMAD RM ALKATIB A GABRILOVE JL
Citation: A. Konig et al., THE NOVEL CYCLIN-DEPENDENT KINASE INHIBITOR FLAVOPIRIDOL DOWN-REGULATES BCL-2 AND INDUCES GROWTH ARREST AND APOPTOSIS IN CHRONIC B-CELL LEUKEMIA LINES, Blood, 90(11), 1997, pp. 4307-4312
THE PROTEIN-KINASE-C INHIBITOR RO-32-0432 ENHANCES FLUDARABINE-INDUCED APOPTOSIS IN WSU-CLL CHRONIC LYMPHOCYTIC-LEUKEMIA CELLS
Authors: KONIG A SCHWARTZ GK ALKATIB A MOHAMMAD RM HARMON C GABRILOVE JL
Citation: A. Konig et al., THE PROTEIN-KINASE-C INHIBITOR RO-32-0432 ENHANCES FLUDARABINE-INDUCED APOPTOSIS IN WSU-CLL CHRONIC LYMPHOCYTIC-LEUKEMIA CELLS, Blood, 90(10), 1997, pp. 3641-3641
A NEW TUBULIN POLYMERIZATION INHIBITOR, AURISTATIN PE, DOWN-REGULATESALTERED P53 AND INDUCES TUMOR-REGRESSION IN A HUMAN WALDENSTROMS MACROGLOBULINEMIA MODEL
Authors: LIMVARAPUSS C MOHAMMAD RM WALL N HAMDY N MEHRA V PETTIT GR ALKATIB A
Citation: C. Limvarapuss et al., A NEW TUBULIN POLYMERIZATION INHIBITOR, AURISTATIN PE, DOWN-REGULATESALTERED P53 AND INDUCES TUMOR-REGRESSION IN A HUMAN WALDENSTROMS MACROGLOBULINEMIA MODEL, Blood, 90(10), 1997, pp. 1458-1458
THE ROLE OF BRYOSTATIN-1 IN 2-CDA RESISTANT B-CLL LINE - MECHANISM OFRESISTANCE AND RESPONSE
Authors: MOHAMMAD RM BECK FWJ WALL N HAMDY N MENDPARA SD LIU KZ SCHULTZ CP HANNOUDI GN MANTSCH HH ALKATIB A
Citation: Rm. Mohammad et al., THE ROLE OF BRYOSTATIN-1 IN 2-CDA RESISTANT B-CLL LINE - MECHANISM OFRESISTANCE AND RESPONSE, Blood, 90(10), 1997, pp. 2364-2364
BRYOSTATIN-1 INDUCES UBIQUITIN COOH-TERMINAL HYDROLASE IN ACUTE LYMPHOBLASTIC-LEUKEMIA CELLS
Authors: MOHAMMAD RM MAKI A PETTIT GR ALKATIB AM
Citation: Rm. Mohammad et al., BRYOSTATIN-1 INDUCES UBIQUITIN COOH-TERMINAL HYDROLASE IN ACUTE LYMPHOBLASTIC-LEUKEMIA CELLS, Enzyme & protein, 49(5-6), 1996, pp. 262-272
ESTABLISHMENT OF A HUMAN B-CLL XENOGRAFT MODEL - UTILITY AS A PRECLINICAL THERAPEUTIC MODEL
Authors: MOHAMMAD RM MOHAMED AN HAMDAN MY VO T CHEN B KATATO K ABUBAKR YA DUGAN MC ALKATIB A
Citation: Rm. Mohammad et al., ESTABLISHMENT OF A HUMAN B-CLL XENOGRAFT MODEL - UTILITY AS A PRECLINICAL THERAPEUTIC MODEL, Leukemia, 10(1), 1996, pp. 130-137
EXPRESSION OF DEUBIQUITINASE IN DIFFERENTIATED ACUTE LYMPHOBLASTIC-LEUKEMIA, REH CELLS
Authors: MOHAMMAD RM ALKATIB A JATON JC
Citation: Rm. Mohammad et al., EXPRESSION OF DEUBIQUITINASE IN DIFFERENTIATED ACUTE LYMPHOBLASTIC-LEUKEMIA, REH CELLS, Experimental hematology, 24(9), 1996, pp. 692-692
Risultati: 1-25 | 26-41